DYAI — DYADIC INTERNATIONAL INC
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1213809 ·
Last close
$0.42
Market Cap
$16.83M
52W High
$1.60
52W Low
$0.34
ADV30
197,857
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 123,886 | -860,279 | -2,045,511 | -2,123,884 | 6,536,531 | 1,425,364 | 8,923,775 |
| Mar 2026 | 623,590 | -168,250 | -1,912,284 | -1,954,683 | 7,809,573 | 4,247,269 | 8,217,305 |
| Dec 2025 | 235,716 | -148,892 | -1,524,929 | -1,567,263 | 9,945,725 | 4,622,331 | 8,713,315 |
| Sep 2025 | 350,046 | -673,957 | -1,912,614 | -1,976,012 | 11,672,757 | 5,834,510 | 9,065,423 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-5,715,824
Investing CF
$866,177
Financing CF
$4,940,695
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.24
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-95,405,791
Inventory
—
Receivables
$1,008,887
ST Investments
$1,361,043
EBIT TTM
$-6,840,216
Pretax Income TTM
$-7,291,732
Interest Exp TTM
$451,516
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,802,237
EBITDA
—
Free Cash Flow
$-4,809,161
Enterprise Value
$19,568,678
Total Cash
$3,113,719
Total Debt
$5,046,064
Shares Out
40,063,703
Trailing EPS
$-0.21
Book Value
$-0.07
ROE
-2826.9%
ROA
-63.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,232,311 | -7,145,916 | -7,364,628 | 9,945,725 | 8,713,315 | 1,232,410 | -5,702,221 |
| Dec 2024 | 3,495,389 | -5,878,261 | -5,809,159 | 9,930,275 | 7,459,985 | 2,470,290 | -3,974,806 |
| Dec 2023 | 2,898,806 | -8,191,322 | -6,795,461 | 8,219,236 | 2,340,651 | 5,878,585 | -6,726,755 |
| Dec 2022 | 2,930,303 | -10,115,760 | -9,735,258 | 13,712,818 | 2,625,079 | 11,087,739 | -8,083,775 |
TTM Snapshot
Revenues TTM
$717,467
NetIncome TTM
$-3,237,879
OpCashFlow TTM
$0
Assets (Latest)
$37,452,496
Forward EPS
$-0.32
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BCDA | BioCardia, Inc. | $15.90M | $1.05 | — |
| PASG | Passage BIO, Inc. | $15.45M | $4.80 | — |
| JSPR | Jasper Therapeutics, Inc. | $20.26M | $0.61 | — |
| ZIVO | Zivo Bioscience, Inc. | $13.91M | $3.30 | — |
| CKDXF | Opthea Ltd | $13.68M | $0.01 | — |
News headlines (Yahoo Finance, 1h cache)
DYAI: Second Quarter Results
2026-08-14 17:02 · Yahoo
Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement
2026-08-13 12:00 · Yahoo
Dyadic International Inc (DYAI) (Q2 2026) Earnings Call Highlights: Revenue Surges 52% as ...
2026-08-13 05:01 · Yahoo
Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas
2026-08-12 12:30 · Yahoo
Dyadic Announces Continued Listing on the Nasdaq Capital Market
2026-07-24 11:30 · Yahoo
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program
2026-07-16 12:00 · Yahoo
Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential
2026-07-07 11:25 · Yahoo
Dyadic Expands IP Protection and Business Development Activities in Japan
2026-06-29 11:25 · Yahoo
An Interview with the President & COO: How Dyadic is Commercializing Its Protein Platform Across Multi-Billion-Dollar Markets
2026-06-22 12:46 · Yahoo
Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption
2026-06-15 11:25 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.